CoChat

Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Open access

The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.

Abstract

Background. Several studies have reported that statins have anti-inflammatory effects. Nevertheless, results of clinical trials concerning the effect of statins on the levels of C-reactive protein (CRP) and high-sensitivity CRP (hs-CRP) have been inconsistent. Therefore, we performed a systematic review and meta-analysis of randomized clinical trials (RCTs) evaluating the effect of statins on CRP and hs-CRP levels in patients with cardiovascular diseases (CVDs). Methods. Literature search of the major databases was performed to find eligible RCTs assessing the effect of statins on serum levels of CRP and hs-CRP from the inception until the last week of April 2021. The effect sizes were determined for weighted mean difference (WMD) and 95% confidence intervals (CI). Results. 26 studies were identified (3010 patients and 2968 controls) for hs-CRP and 20 studies (3026 patients and 2968 controls) for CRP. Statins reduced the serum levels of hs-CRP ( WMD = − 0.97 mg / L ; 95% CI: -1.26 to -0.68 mg/L; P < 0.001 ) and CRP ( WMD = − 3.05 mg / L ; 95% CI: -4.86 to -1.25 mg/L; P < 0.001 ) in patients with CVDs. Statins decreased the serum levels of hs-CRP in patients receiving both high-intensity and moderate/low-intensity treatments with these drugs. In addition, the duration of treatment longer than 10 weeks decreased hs-CRP levels. Only high-intensity statin treatment could marginally decrease serum levels of CRP in CVDs patients. Conclusions. This meta-analysis showed the efficacy of statins to reduce the concentrations of CRP and hs-CRP in patients with different types of CVDs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2022/8732360

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 PRISMA flow diagram of the study selection process.
Figure 1 PRISMA flow diagram of the study selection process.CC BY · PubMed Central
Figure 2 Forest plot presenting WMD and 95% CI for the effect of statin administration on hs-CRP (a) and CRP (b) levels in the overall population.
Figure 2 Forest plot presenting WMD and 95% CI for the effect of statin administration on hs-CRP (a) and CRP (b) levels in the overall population.CC BY · PubMed Central
Figure 3 Forest plot presenting WMD and 95% CI for the effect of statin administration on hs-CRP and CRP levels in subgroup analysis by dose; (a) hs-CRP and (b) CRP.
Figure 3 Forest plot presenting WMD and 95% CI for the effect of statin administration on hs-CRP and CRP levels in subgroup analysis by dose; (a) hs-CRP and (b) CRP.CC BY · PubMed Central
Figure 4 Trial sequence analysis of all the included studies for the effect of statin administration on the serum levels of hs-CRP (a) and CRP (b). Cumulative Z-curve (dashed blue lines), conventional boundary (green horizontal lines), trial sequential monitoring boundaries (inward sloping purple line), and required information sizes (purple vertical lines).
Figure 4 Trial sequence analysis of all the included studies for the effect of statin administration on the serum levels of hs-CRP (a) and CRP (b). Cumulative Z-curve (dashed blue lines), conventional boundary (green horizontal lines), trial sequential monitoring boundaries (inward sloping purple line), and required information sizes (purple vertical lines).CC BY · PubMed Central
Figure 5 Nonlinear dose-response relations between dosage statin administration and WMD in hs-CRP: (a) high dose of statins and (b) moderate/low dose of statins.
Figure 5 Nonlinear dose-response relations between dosage statin administration and WMD in hs-CRP: (a) high dose of statins and (b) moderate/low dose of statins.CC BY · PubMed Central
Figure 6 Random effects metaregression plots of the association between WMD of hs-CRP, CRP, and statin administration based on (a) hs-CRP (dosage), (b) hs-CRP (publication year), (c) CRP (dosage), and (d) CRP (treatment duration).
Figure 6 Random effects metaregression plots of the association between WMD of hs-CRP, CRP, and statin administration based on (a) hs-CRP (dosage), (b) hs-CRP (publication year), (c) CRP (dosage), and (d) CRP (treatment duration).CC BY · PubMed Central
Figure 7 Funnel plot detailing publication biases in the studies included in the meta-analysis; (a) hs-CRP and (b) CRP.
Figure 7 Funnel plot detailing publication biases in the studies included in the meta-analysis; (a) hs-CRP and (b) CRP.CC BY · PubMed Central
Figure 8 Leave-one-out sensitivity analyses of the statin therapy effect on serum hs-CRP (a) and CRP (b) level.
Figure 8 Leave-one-out sensitivity analyses of the statin therapy effect on serum hs-CRP (a) and CRP (b) level.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 101 references

Cited by

See all 156

Metadata

Authors
Kandelouei, T., Abbasifard, M., Imani, D., Aslani, S., Razi, B., Fasihi, M., Shafiekhani, S., Mohammadi, K., Jamialahmadi, T., Reiner, Ž., & Sahebkar, A.
Affiliations
  • University of Utah (US)
  • Rafsanjan University of Medical Sciences (IR)
  • Tehran University of Medical Sciences (IR)
  • Tarbiat Modares University (IR)
  • Mashhad University of Medical Sciences (IR)
  • University Hospital Centre Zagreb (HR)
Corresponding author
  • Razi, Bahman
  • Sahebkar, Amirhossein
Venue
Mediators of Inflammation
Publisher
Wiley
Published
2022-01-28
Volume
2022
Pages
1-20
ISSN
  • 0962-9351 (ISSN-L)
  • 1466-1861
OpenAlex
W4210294380
Cited by
136
References
101
Citations by year
2026: 18 · 2025: 35 · 2024: 38 · 2023: 30 · 2022: 14
FWCI
6.95
Type
journal article
Language
en
Open access
Locations
  • Mediators of Inflammation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
statins, high-sensitivity C-reactive protein, C-reactive protein, cardiovascular disease, anti-inflammatory activity, statin intensity, treatment duration
MeSH terms
C-Reactive Protein, Cardiovascular Diseases, Humans, Randomized Controlled Trials as Topic, Hydroxymethylglutaryl-CoA Reductase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. https://app.cochat.ai/papers/10.1155/2022/8732360
The paper
Kandelouei, T., Abbasifard, M., Imani, D., Aslani, S., Razi, B., Fasihi, M., Shafiekhani, S., Mohammadi, K., Jamialahmadi, T., Reiner, Ž., & Sahebkar, A. (2022). Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Mediators of Inflammation. https://doi.org/10.1155/2022/8732360

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.